ADB-FUBICA

ADB-FUBICA
Legal status
Legal status	CA: Schedule II; DE: NpSG (Industrial and scientific use only); UK: Class B;
Identifiers
	IUPAC name (S)-N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide;
CAS Number	1801338-23-7 ;
UNII	S3ABP24K72;
Chemical and physical data
Formula	C22H24FN3O2
Molar mass	381.451 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(C1=CN(CC2=CC=C(F)C=C2)C3=C1C=CC=C3)N[C@@H](C(C)(C)C)C(N)=O;
	InChI InChI=1S/C22H24FN3O2/c1-22(2,3)19(20(24)27)25-21(28)17-13-26(18-7-5-4-6-16(17)18)12-14-8-10-15(23)11-9-14/h4-11,13,19H,12H2,1-3H3,(H2,24,27)(H,25,28)/t19-/m1/s1; Key:QIFOZYUACLDTAJ-LJQANCHMSA-N;

ADB-FUBICA is a drug that acts as a potent agonist for the cannabinoid receptors, with EC₅₀ values of 2.6 nM at CB₁ and 3.0 nM at CB₂.[1][2]

References

Banister SD, Moir M, Stuart J, Kevin RC, Wood KE, Longworth M, et al. (September 2015). "Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA". ACS Chemical Neuroscience. 6 (9): 1546–59. doi:10.1021/acschemneuro.5b00112. PMID 26134475.
Qian Z, Hua Z, Liu C, Jia W (November 2015). "Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances". Forensic Toxicology. 34: 133–143. doi:10.1007/s11419-015-0297-2. PMC 4705129. PMID 26793280.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.